The Utility of ERG/P63 Double Immunohistochemical Staining in the Diagnosis of Limited Cancer in Prostate Needle Biopsies

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Surgical Pathology

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PAS.0b013e318215cc03PMID 21623182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

  2010influential reference
• ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

  2010cited by this paper
• Antibody-based detection of ERG rearrangement-positive prostate cancer.

  2010influential reference
• Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

  2009cited by this paper
• ETS gene fusions in prostate cancer

  2009cited by this paper
• Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

  2009influential reference
• Aberrant Diffuse Expression of p63 in Adenocarcinoma of the Prostate on Needle Biopsy and Radical Prostatectomy: Report of 21 Cases

  2009cited by this paper
• Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications

  2008cited by this paper
• Recurrent gene fusions in prostate cancer

  2008cited by this paper
• Partial Atrophy on Prostate Needle Biopsy Cores: A Morphologic and Immunohistochemical Study

  2008cited by this paper
• Partial Atrophy in Prostate Needle Biopsies: A Detailed Analysis of Its Morphology, Immunophenotype, and Cellular Kinetics

  2008cited by this paper
• Aberrant Diffuse Expression of p63 in Adenocarcinoma of the Prostate on Needle Biopsy and Radical Prostatectomy: Report of 21 Cases

  2008cited by this paper
• Diagnosis of adenocarcinoma in prostate needle biopsy tissue

  2007influential reference
• Immunohistochemistry in diagnostic surgical pathology of the prostate.

  2005cited by this paper
• Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature

  2005cited by this paper
• Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy

  2004influential reference
• Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

  2004cited by this paper
• Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.

  2004influential reference
• Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.

  2004cited by this paper
• Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

  2004cited by this paper
• Expression and Diagnostic Utility of Alpha-Methylacyl-CoA-Racemase (P504S) in Foamy Gland and Pseudohyperplastic Prostate Cancer

  2003cited by this paper
• Comparison of the Basal Cell-Specific Markers, 34&bgr;E12 and p63, in the Diagnosis of Prostate Cancer

  2002cited by this paper
• Diagnostic Utility of Immunohistochemical Staining for p63, a Sensitive Marker of Prostatic Basal Cells

  2002cited by this paper
• alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

  2002influential reference
• Expression of &agr;-Methylacyl-CoA Racemase (P504S) in Atypical Adenomatous Hyperplasia of the Prostate

  2002cited by this paper
• P504S Immunohistochemical Detection in 405 Prostatic Specimens Including 376 18-Gauge Needle Biopsies

  2002cited by this paper
• P504S: A New Molecular Marker for the Detection of Prostate Carcinoma

  2001cited by this paper
• Early detection of prostate cancer.

  1998cited by this paper
• Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma.

  1995cited by this paper
• Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory.

  1995cited by this paper
• Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.

  1993cited by this paper
• Early detection of prostate cancer.

  1992cited by this paper

• The relevance of ERG immunoexpression intensity for prostatic adenocarcinoma in radical prostatectomy of 635 samples.

  2023cites this paper
• Diagnostic utility of immunohistochemical markers alpha methyl acyl coA racemase (AMACR) and Ets related gene (ERG) in prostate cancer.

  2022cites this paper
• Evaluation of ERG Expression in Prostate Adenocarcinoma and Its Prognostic Impact in Patients Survival Rate

  2021cites this paper
• Expression of ERG immunohistochemical stain in prostatic adenocarcinoma

  2021cites this paper
• Practical Genitourinary Pathology: Frequently Asked Questions

  2021cites this paper
• Practical Application of Lineage-Specific Immunohistochemistry Markers: Transcription Factors (Sometimes) Behaving Badly.

  2020cites this paper
• Prostate Pathology

  2020cites this paper
• Neoplasms of the Prostate

  2020cites this paper
• Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma

  2019cites this paper
• ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients

  2019cites this paper
• RRU_A_207843 149..155

  2019cites this paper
• Immunohistochemical expression of ERG and P63 in some prostatic lesions

  2019cites this paper
• Pathology of the Prostate: An Algorithmic Approach

  2018cites this paper
• Variants of acinar adenocarcinoma of the prostate mimicking benign conditions

  2018cites this paper
• Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update

  2018cites this paper
• High-Grade Prostatic Intraepithelial Neoplasia

  2018cites this paper
• Prostate cancer in Jordanian-Arab population: ERG status and relationship with clinicopathologic characteristics

  2017cites this paper
• Correlation between ERG Fusion Protein and Androgen Receptor Expression by Immunohistochemistry in Prostate, Possible Role in Diagnosis and Therapy

  2017cites this paper
• p63 protects chondrosarcoma malignancies mainly by enhancing the expression of PTEN.

  2017cites this paper
• New and Emerging Diagnostic and Prognostic Immunohistochemical Biomarkers in Prostate Pathology

  2017cites this paper
• Practical Immunohistochemistry of Prostate Cancer and Related Lesions

  2017cites this paper
• Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions

  2017cites this paper
• ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.

  2016cites this paper
• Award Number: W81XWH-13-1-0271 TITLE: Molecular Profiling of Intraductal Carcinoma of the Prostate PRINCIPAL INVESTIGATOR:

  2016cites this paper
• High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer

  2016cites this paper
• ERG expression in prostate cancer: biological relevance and clinical implication

  2016influential citation
• ERG Expression in Prostate Needle Biopsy: Potential Diagnostic and Prognostic Implications

  2015cites this paper
• Current State of ERG as Biomarker in Prostatic Adenocarcinoma.

  2015cites this paper
• Gene Fusions in Prostate Cancer

  2015cites this paper
• New Molecular Markers of Diagnosis and Prognosis in Prostate Cancer

  2015cites this paper
• Evaluation of the TMPRSS2:ERG fusion for the detection of prostate cancer: a systematic review and meta-analysis

  2014cites this paper
• ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer.

  2014cites this paper
• Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology: Report From the International Society of Urological Pathology Consensus Conference

  2014cites this paper
• Best Practices Recommendations in the Application of Immunohistochemistry in the Prostate: Report From the International Society of Urologic Pathology Consensus Conference

  2014cites this paper
• p63 is more sensitive and specific than 34βE12 to differentiate adenocarcinoma of prostate from cancer mimickers

  2014cites this paper
• The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.

  2014cites this paper
• A concise update on prostate pathology.

  2014cites this paper
• The application of immunohistochemical biomarkers in urologic surgical pathology.

  2014cites this paper
• Utility of ERG Versus AMACR Expression in Diagnosis of Minimal Adenocarcinoma of the Prostate in Needle Biopsy Tissue

  2014cites this paper
• ETS fusion genes in prostate cancer.

  2014influential citation
• Tumors of the genitourinary system

  2014cites this paper
• Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.

  2013cites this paper
• Clinical Applications of Novel ERG Immunohistochemistry in Prostate Cancer Diagnosis and Management

  2013cites this paper
• Novel Dual Color Immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma

  2013cites this paper
• Androgen-Dependent Oncogenic Activation of ETS Transcription Factors by Recurrent Gene Fusions in Prostate Cancer: Biological and Clinical Implications

  2013cites this paper
• ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.

  2013cites this paper
• Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3‐ERG gene rearrangement and an unfavorable clinical course

  2013cites this paper
• Foamy Gland Carcinoma of the Prostate in Needle Biopsy: Incidence, Gleason Grade, and Comparative &agr;-Methylacyl-CoA Racemase vs. ERG Expression

  2013cites this paper
• ERG expression and prostatic adenocarcinoma

  2013cites this paper
• Pathological Implications of Prostate Biopsy

  2013cites this paper
• Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma

  2013cites this paper
• Frequency of ERG-positive prostate carcinoma in Polands.

  2013cites this paper
• ERG protein expression as a biomarker of prostate cancer.

  2013cites this paper
• Clinical implications of current developments in genitourinary pathology.

  2013cites this paper
• Immunohistochemical evaluation of ERG expression in various benign and malignant tissues.

  2013cites this paper
• The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.

  2013cites this paper
• Making personalized prostate cancer medicine a reality: challenges and opportunities in the re-establishment of gold standards.

  2013cites this paper
• Early Detection and Patient Risk Stratification in Prostate Cancer

  2013cites this paper
• Clinical potential of the ERG oncoprotein in prostate cancer

  2012cites this paper
• Diagnostic and prognostic molecular biomarkers for prostate cancer

  2012cites this paper
• Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN

  2012cites this paper
• Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.

  2012cites this paper
• Precursors of prostate cancer

  2012cites this paper
• ERG protein expression in human tumors detected with a rabbit monoclonal antibody.

  2012cites this paper
• Quoi de neuf en uropathologie

  2012cites this paper
• Update on prostate pathology

  2012cites this paper
• Diagnosis of limited adenocarcinoma of the prostate

  2012cites this paper
• ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality.

  2012cites this paper
• Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden.

  2012cites this paper
• Difficultés d’interprétation des biopsies prostatiques. Cas no 1. Microfoyer d’adénocarcinome acinaire

  2012cites this paper
• [Diagnostic issues of prostate biopsies. Case 1. Limited adenocarcinoma].

  2012cites this paper
• Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia

  2012cites this paper
• Anatomic Pathology / ERG in Human Tumors

  2012cites this paper
• Oncogenic activation of ERG: A predominant mechanism in prostate cancer

  2011cites this paper